A revolutionary new approach to tissue injury and repair
Under Construction
Avipero Ltd is a privately held start-up company established in 2009. AVIPERO is uniquely positioned in the area of integrin therapeutic as we have a proprietary, patented treatment for inducing tissue repair through a mechanism that may revolutionise the treatment of many
debilitating and degenerative conditions. This treatment was discovered by Rehab AlJamal-Naylor and David Harrison in 2002. The main diseases where preclinical efficacy has been shown are Chronic Obstructive Pulmonary Disease (COPD), Parkinson’s disease and arthritis.